Advance Care Planning in Patients Undergoing Hematopoietic Cell Transplantation

Biology of Blood and Marrow Transplantation

Volumn 13, Issue 1, 2007, Pages 65-73

  Joffe, Steven ^a,b   Mello, Michelle M ^c   Cook, E Francis ^c,d   Lee, Stephanie J ^a,d  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Advance care planning; advance directives; end of life care; health care proxy; hematopoietic cell transplantation; living well

Indexed keywords

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CONTROLLED STUDY; DEATH; FAMILY; FEMALE; FRIEND; HEALTH CARE PLANNING; HEALTH SURVEY; HIGH RISK PATIENT; HUMAN; LIVING WILL; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MEDICAL RECORD; PATIENT CARE; PHYSICIAN; POPULATION RESEARCH; PREVALENCE;

ADULT; ADVANCE CARE PLANNING; DATA COLLECTION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LIVING WILLS; LONGITUDINAL STUDIES; MALE; MEDICAL RECORDS; MIDDLE AGED; PHYSICIAN-PATIENT RELATIONS; QUESTIONNAIRES;

EID: 33845986722     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2006.08.042     Document Type: Article

References (45)

1. Loberiza Jr. F.R., Zhang M.J., Lee S.J., et al. Association of transplant center and physician factors on mortality after hematopoietic stem cell transplantation in the United States. Blood 105 (2005) 2979-2987
2. Perry A.R., Rivlin M.M., and Goldstone A.H. Bone marrow transplant patients with life-threatening organ failure: when should treatment stop?. J Clin Oncol 17 (1999) 298-303
3. Fagerlin A., and Schneider C.E. Enough: the failure of the living will. Hastings Cent Rep 34 (2004) 30-42
4. Ganti A.K., Lee S.J., Armitage J.O., et al. Outcomes following hematopoietic stem cell transplantation for hematologic malignancies in patients with or without advance care planning. [abstract]. Blood 106 (2005) 242
5. Lee S.J., Loberiza F.R., Antin J.H., et al. Routine screening for psychosocial distress following hematopoietic stem cell transplantation. Bone Marrow Transplant 35 (2005) 77-83
6. Alyea E.P., Kim H.T., Ho V., et al. Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age. Blood 105 (2005) 1810-1814
7. Alyea E.P., Weller E., Fisher D.C., et al. Comparable outcome with T-cell-depleted unrelated-donor versus related-donor allogeneic bone marrow transplantation. Biol Blood Marrow Transplant 8 (2002) 601-607
8. Antin J.H., Kim H.T., Cutler C., et al. Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation. Blood 102 (2003) 1601-1605
9. Cutler C., Kim H.T., Hochberg E., et al. Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation. Biol Blood Marrow Transplant 10 (2004) 328-336
10. Ho V.T., Kim H.T., Li S., et al. Partial CD8+ T-cell depletion of allogeneic peripheral blood stem cell transplantation is insufficient to prevent graft-versus-host disease. Bone Marrow Transplant 34 (2004) 987-994
11. Lee S.J., Fairclough D., Antin J.H., et al. Discrepancies between patient and physician estimates for the success of stem cell transplantation. JAMA 285 (2001) 1034-1038
12. Lee S.J., Fairclough D., Parsons S.K., et al. Recovery after stem cell transplantation for hematologic diseases. J Clin Oncol 19 (2001) 242-252
13. Steinhauser K.E., Christakis N.A., Clipp E.C., et al. Factors considered important at the end of life by patients, family, physicians, and other care providers. JAMA 284 (2000) 2476-2482
14. Ware Jr. J., Kosinski M., and Keller S.D. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 34 (1996) 220-233
15. Oken M.M., Creech R.H., Tormey D.C., et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5 (1982) 649-655
16. Bradley E.H., Hallemeier A.G., Fried T.R., et al. Documentation of discussions about prognosis with terminally ill patients. Am J Med 111 (2001) 218-223
17. Yang A.D., Bentrem D.J., Pappas S.G., et al. Advance directive use among patients undergoing high-risk operations. Am J Surg 188 (2004) 98-101
18. Emanuel L.L., Barry M.J., Stoeckle J.D., et al. Advance directives for medical care: a case for greater use. N Engl J Med 324 (1991) 889-895
19. Teno J., Lynn J., Wenger N., et al. Advance directives for seriously ill hospitalized patients: effectiveness with the Patient Self-Determination Act and the SUPPORT intervention. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment. J Am Geriatr Soc 45 (1997) 500-507
20. Jacobson J.A., Kasworm E., Battin M.P., et al. Advance directives in Utah: information from death certificates and informants. Arch Intern Med 156 (1996) 1862-1868
21. Emanuel E.J., Weinberg D.S., Gonin R., et al. How well is the Patient Self-Determination Act working?. An early assessment. Am J Med 95 (1993) 619-628
22. Goodman M.D., Tarnoff M., and Slotman G.J. Effect of advance directives on the management of elderly critically ill patients. Crit Care Med 26 (1998) 701-704
23. Teno J.M., Branco K.J., Mor V., et al. Changes in advance care planning in nursing homes before and after the Patient Self-Determination Act: report of a 10-state survey. J Am Geriatr Soc 45 (1997) 939-944
24. Hanson L.C., and Rodgman E. The use of living wills at the end of life: a national study. Arch Intern Med 156 (1996) 1018-1022
25. McKinley E.D., Garrett J.M., Evans A.T., et al. Differences in end-of-life decision making among black and white ambulatory cancer patients. J Gen Intern Med 11 (1996) 651-656
26. Gamble E.R., McDonald P.J., and Lichstein P.R. Knowledge, attitudes, and behavior of elderly persons regarding living wills. Arch Intern Med 151 (1991) 277-280
27. Casarett D.J., Hirschman K.B., and Henry M.R. Does hospice have a role in nursing home care at the end of life?. J Am Geriatr Soc 49 (2001) 1493-1498
28. Hammes B.J., and Rooney B.L. Death and end-of-life planning in one midwestern community. Arch Intern Med 158 (1998) 383-390
29. Greiner K.A., Perera S., and Ahluwalia J.S. Hospice usage by minorities in the last year of life: results from the National Mortality Followback Survey. J Am Geriatr Soc 51 (2003) 970-978
30. Phipps E., True G., Harris D., et al. Approaching the end of life: attitudes, preferences, and behaviors of African-American and white patients and their family caregivers. J Clin Oncol 21 (2003) 549-554
31. Lamont E.B., and Siegler M. Paradoxes in cancer patients' advance care planning. J Palliat Med 3 (2000) 27-35
32. Haas J.S., Weissman J.S., Cleary P.D., et al. Discussion of preferences for life-sustaining care by persons with AIDS: predictors of failure in patient-physician communication. Arch Intern Med 153 (1993) 1241-1248
33. Reilly B.M., Wagner M., Ross J., et al. Promoting completion of health care proxies following hospitalization: a randomized controlled trial in a community hospital. Arch Intern Med 155 (1995) 2202-2206
34. Pearlman R.A., Starks H., Cain K.C., et al. Improvements in advance care planning in the Veterans Affairs System: results of a multifaceted intervention. Arch Intern Med 165 (2005) 667-674
35. Hofmann J.C., Wenger N.S., Davis R.B., et al. Patient preferences for communication with physicians about end-of-life decisions. Study to Understand Prognoses and Preference for Outcomes and Risks of Treatment. Ann Intern Med 127 (1997) 1-12
36. Miller B.E., Pittman B., and Strong C. Gynecologic cancer patients' psychosocial needs and their views on the physician's role in meeting those needs. Int J Gynecol Cancer 13 (2003) 111-119
37. Danis M., Southerland L.I., Garrett J.M., et al. A prospective study of advance directives for life-sustaining care. N Engl J Med 324 (1991) 882-888
38. Teno J.M., Licks S., Lynn J., et al. Do advance directives provide instructions that direct care?. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment. J Am Geriatr Soc 45 (1997) 508-512
39. Kish Wallace S., Martin C.G., Shaw A.D., et al. Influence of an advance directive on the initiation of life support technology in critically ill cancer patients. Crit Care Med 29 (2001) 2294-2298
40. Tilden V.P., Tolle S.W., Nelson C.A., et al. Family decision-making to withdraw life-sustaining treatments from hospitalized patients. Nurs Res 50 (2001) 105-115
41. Emanuel E.J., and Emanuel L.L. Proxy decision making for incompetent patients: an ethical and empirical analysis. JAMA 267 (1992) 2067-2071
42. Uhlmann R.F., Pearlman R.A., and Cain K.C. Physicians' and spouses' predictions of elderly patients' resuscitation preferences. J Gerontol 43 (1988) M115-M121
43. Zweibel N.R., and Cassel C.K. Treatment choices at the end of life: a comparison of decisions by older patients and their physician-selected proxies. Gerontologist 29 (1989) 615-621
44. Seckler A.B., Meier D.E., Mulvihill M., et al. Substituted judgment: how accurate are proxy predictions?. Ann Intern Med 115 (1991) 92-98
45. Institute of Medicine Committee on Care at the End of Life. Approaching Death: Improving Care at the End of Life (1997), National Academy Press, Washington, DC